RadNet executives will present at the J.P. Morgan Healthcare Conference on January 14, 2026, in San Francisco.
Quiver AI Summary
RadNet, Inc. announced that key executives, including Dr. Howard Berger (CEO) and Mark Stolper (CFO), will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, at 10:30 a.m. PST in San Francisco. The presentation will be available via live webcast and for later viewing. RadNet is a leading provider of diagnostic imaging services in the U.S., operating 407 outpatient imaging centers across multiple states, and also offers radiology technology and artificial intelligence solutions. The company employs over 11,000 people and aims to provide high-quality, cost-effective imaging services.
Potential Positives
- RadNet, Inc. will be presenting at the prestigious 44th Annual J.P. Morgan Healthcare Conference, showcasing their leadership in the diagnostic imaging sector.
- The participation of top executives, including the CEO and CFO, highlights the company's commitment to transparency and investor engagement.
- The availability of a live webcast for the presentation allows for wider accessibility, promoting greater awareness of RadNet's services and innovations.
- With 407 outpatient imaging centers and over 11,000 team members, RadNet's significant scale underscores its position as a national leader in the diagnostic imaging market.
Potential Negatives
- None
FAQ
What is the date and time of RadNet's presentation at the J.P. Morgan Healthcare Conference?
RadNet's presentation is scheduled for Wednesday, January 14, 2026, at 10:30 a.m. PST.
Where can I watch the live webcast of RadNet's presentation?
The live webcast of RadNet's presentation can be accessed at https://jpmorgan.metameetings.net/events/healthcare26/sessions/317344-radnet-inc/webcast?gpu_only=true&kiosk=true.
Who are the key speakers at RadNet's presentation?
Key speakers include Dr. Howard Berger, Mark Stolper, Dr. Gregory Sorensen, and Kees Wesdorp.
What services does RadNet, Inc. provide?
RadNet offers high-quality diagnostic imaging services, radiology technology solutions, teleradiology, and related products in the imaging industry.
How many imaging centers does RadNet operate?
RadNet operates a network of 407 owned and/or operated outpatient imaging centers across multiple states in the U.S.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$RDNT Insider Trading Activity
$RDNT insiders have traded $RDNT stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $RDNT stock by insiders over the last 6 months:
- RANJAN JAYANATHAN (Chief Information Officer) sold 65,598 shares for an estimated $4,427,865
- MITAL PATEL (EVP of Fin Planning, CAO) has made 0 purchases and 3 sales selling 50,000 shares for an estimated $3,902,254.
- STEPHEN M FORTHUBER (Pres & COO-Eastern Operations) has made 0 purchases and 3 sales selling 45,088 shares for an estimated $3,531,848.
- MARK STOLPER (EVP, Chief Financial Officer) sold 35,000 shares for an estimated $2,586,150
- DAVID JEFFREY KATZ (EVP and Chief Legal Officer) has made 0 purchases and 2 sales selling 31,000 shares for an estimated $2,203,430.
- NORMAN R HAMES (Pres and COO-West Operations) has made 0 purchases and 2 sales selling 15,000 shares for an estimated $1,082,900.
- CORNELIS WESDORP (Pres & CEO, Digital Health) has made 0 purchases and 3 sales selling 2,500 shares for an estimated $172,530.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RDNT Revenue
$RDNT had revenues of $522.9M in Q3 2025. This is an increase of 13.39% from the same period in the prior year.
You can track RDNT financials on Quiver Quantitative's RDNT stock page.
$RDNT Hedge Fund Activity
We have seen 179 institutional investors add shares of $RDNT stock to their portfolio, and 140 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,924,549 shares (+1312.8%) to their portfolio in Q3 2025, for an estimated $146,669,879
- POLAR CAPITAL HOLDINGS PLC added 832,214 shares (+inf%) to their portfolio in Q3 2025, for an estimated $63,423,028
- VAN BERKOM & ASSOCIATES INC. added 817,808 shares (+14163.6%) to their portfolio in Q3 2025, for an estimated $62,325,147
- ROCKEFELLER CAPITAL MANAGEMENT L.P. added 771,859 shares (+733.7%) to their portfolio in Q3 2025, for an estimated $58,823,374
- FULLER & THALER ASSET MANAGEMENT, INC. added 705,659 shares (+inf%) to their portfolio in Q3 2025, for an estimated $53,778,272
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 646,924 shares (+152.1%) to their portfolio in Q3 2025, for an estimated $49,302,078
- WESTFIELD CAPITAL MANAGEMENT CO LP added 525,820 shares (+inf%) to their portfolio in Q3 2025, for an estimated $40,072,742
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RDNT Analyst Ratings
Wall Street analysts have issued reports on $RDNT in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B. Riley Securities issued a "Buy" rating on 12/01/2025
- Barclays issued a "Overweight" rating on 11/13/2025
To track analyst ratings and price targets for $RDNT, check out Quiver Quantitative's $RDNT forecast page.
$RDNT Price Targets
Multiple analysts have issued price targets for $RDNT recently. We have seen 4 analysts offer price targets for $RDNT in the last 6 months, with a median target of $86.5.
Here are some recent targets:
- Yuan Zhi from B. Riley Securities set a target price of $87.0 on 12/01/2025
- Andrew Mok from Barclays set a target price of $86.0 on 11/13/2025
- David Macdonald from Truist Securities set a target price of $90.0 on 11/12/2025
- John Ransom from Raymond James set a target price of $75.0 on 08/13/2025
Full Release
LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, Mark Stolper, Executive Vice President and Chief Financial Officer, Dr. Gregory Sorensen, Executive Vice President and Chief Strategy Officer and Kees Wesdorp, President & CEO of RadNet Digital Health will be presenting at the 44 th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 14, 2026 at 10:30 a.m. PST.
A live webcast of RadNet's presentation can be accessed through the following link,
https://jpmorgan.metameetings.net/events/healthcare26/sessions/317344-radnet-inc/webcast?gpu_only=true&kiosk=true [jpmorga
n
.metameetings.net]
and is available for replay viewing.
|
Details for RadNet's Presentation:
|
|
|
Date:
Time: Location: |
Wednesday, January 14th, 2026
10:30 a.m. PST The Westin St. Francis Hotel, San Francisco, CA |
About RadNet, Inc.
RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 407 owned and/or operated outpatient imaging centers. RadNet’s markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 11,000 team members. www.radnet.com
Contacts:
RadNet, Inc.
Jane Mazur
Senior Vice President, Corporate Communications
585-355-5978
[email protected]
Mark Stolper, Executive Vice President and Chief Financial Officer
310-445-2800